Pfizer Inc. agreed to delay implementation of planned price increases for certain drugs a day after President Donald Trump launched an attack on the company.
Pfizer Inc. price increases Related: Trump proposal to cut drug prices promises immediate impact Copyright 2018 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.
May 06, 2026
Aetna, meanwhile, is talk about its efforts to adopt a low-friction prior authorization strategy.
May 06, 2026
The framework links U.S. drug prices to international benchmarks through manufacturer agreements and federal pricing mechanisms, with major implications for high-cost drugs like GLP-1s.
May 06, 2026
Fifty-four percent of workers would give up at least one workplace perk for employer-covered GLP-1 treatment.